NEW YORK – CancerIQ on Thursday announced that it has raised $4.8 million to expand its precision health platform, which is designed to help hospitals personalize cancer prevention and treatment strategies based on genomics.
The Chicago-based precision medicine software startup raised the funds through a Series A round led by HealthX Ventures, a digital health-focused venture capital firm.